Camargo Luis Fernando Aranha, De Marco Fernando Vinícius, Barbas Carmen Sílvia Valente, Hoelz Cristiane, Bueno Marco Aurélio Scarpinella, Rodrigues Milton, Amado Verônica Moreira, Caserta Raquel, Martino Marinês Dalla Valle, Pasternak Jacyr, Knobel Elias
Intensive Care Unit, Hospital Israelita Albert Einstein, São Paulo, Brasil.
Crit Care. 2004 Dec;8(6):R422-30. doi: 10.1186/cc2965. Epub 2004 Oct 14.
Deferred or inappropriate antibiotic treatment in ventilator-associated pneumonia (VAP) is associated with increased mortality, and clinical and radiological criteria are frequently employed to establish an early diagnosis. Culture results are used to confirm the clinical diagnosis and to adjust or sometimes withdraw antibiotic treatment. Tracheal aspirates have been shown to be useful for these purposes. Nonetheless, little is known about the usefulness of quantitative findings in tracheal secretions for diagnosing VAP.
To determine the value of quantification of bacterial colonies in tracheal aspirates for diagnosing VAP, we conducted a prospective follow-up study of 106 intensive care unit patients who were under ventilatory support. In total, the findings from 219 sequential weekly evaluations for VAP were examined. Clinical and radiological parameters were recorded and evaluated by three independent experts; a diagnosis of VAP required the agreement of at least two of the three experts. At the same time, cultures of tracheal aspirates were analyzed qualitatively and quantitatively (10(5) colony-forming units [cfu]/ml and 10(6) cfu/ml)
Quantitative cultures of tracheal aspirates (10(5) cfu/ml and 10(6) cfu/ml) exhibited increased specificity (48% and 78%, respectively) over qualitative cultures (23%), but decreased sensitivity (26% and 65%, respectively) as compared with the qualitative findings (81%). Quantification did not improve the ability to predict a diagnosis of VAP.
Quantitative cultures of tracheal aspirates in selected critically ill patients have decreased sensitivity when compared with qualitative results, and they should not replace the latter to confirm a clinical diagnosis of VAP or to adjust antimicrobial therapy.
呼吸机相关性肺炎(VAP)中抗生素治疗延迟或不当与死亡率增加相关,临床和影像学标准常被用于早期诊断。培养结果用于确认临床诊断并调整或有时停用抗生素治疗。气管吸出物已被证明可用于这些目的。然而,关于气管分泌物定量结果对诊断VAP的有用性知之甚少。
为了确定气管吸出物中细菌菌落定量对诊断VAP的价值,我们对106例接受通气支持的重症监护病房患者进行了一项前瞻性随访研究。总共检查了219次连续每周对VAP的评估结果。临床和影像学参数由三位独立专家记录和评估;VAP的诊断需要三位专家中至少两位达成一致。同时,对气管吸出物进行定性和定量培养(10⁵菌落形成单位[cfu]/ml和10⁶ cfu/ml)。
与定性培养(23%)相比,气管吸出物的定量培养(10⁵ cfu/ml和10⁶ cfu/ml)特异性分别提高(分别为48%和78%),但与定性结果(81%)相比敏感性降低(分别为26%和65%)。定量并未提高预测VAP诊断的能力。
与定性结果相比,选定重症患者气管吸出物的定量培养敏感性降低,它们不应替代定性结果来确认VAP的临床诊断或调整抗菌治疗。